The European Medicines Agency (EMA) said on Friday there is a possible link to rare cases of venous thromboembolism (VTE) with the COVID-19 vaccine Janssen made by Johnson & Johnson.
The VTE was included in the risk management plan for vaccine Janssen as a safety concern to be investigated, said EMA in a statement.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3